BlackRock acquired 2.95M Novartis AG shares worth $438M. That's 0.01% of their equity portfolio (1216th largest holding). The first Novartis AG trade was made in Q4 2020. Since then BlackRock bought shares fourteen more times and sold shares on three occasions. The stake costed the investor $296M, netting the investor a gain of 48% so far.
Swiss pharma giant Novartis sees Q3 income up by a quarter, allowing it to achieve its FY guidance and countering the fall in generic drug sales Stateside. B...
Swiss drugmaker Novartis is exploring options to add more medicines to its direct to patient platform that is expected to launch in the U.S. next month, CEO ...
The Swiss drugmaker announced its biggest deal in a decade on Sunday, as its set to buy Avidity Biosciences for about $12 billion. "We have adequate firepow...
The drugmaker reported third-quarter profit of $3.93 billion after higher sales for key drugs allowed it to offset a hit from patent expirations.